These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 37779140)

  • 21. Enhanced immunogenicity induced by mRNA vaccines with various lipid nanoparticles as carriers for SARS-CoV-2 infection.
    Zhang Y; Wang J; Xing H; Liu C; Zha W; Dong S; Jiang Y; Li X
    J Mater Chem B; 2023 Aug; 11(31):7454-7465. PubMed ID: 37448376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of lipid components in lipid nanoparticles for vaccines and gene therapy.
    Hald Albertsen C; Kulkarni JA; Witzigmann D; Lind M; Petersson K; Simonsen JB
    Adv Drug Deliv Rev; 2022 Sep; 188():114416. PubMed ID: 35787388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV
    Valentin A; Bergamaschi C; Rosati M; Angel M; Burns R; Agarwal M; Gergen J; Petsch B; Oostvogels L; Loeliger E; Chew KW; Deeks SG; Mullins JI; Pavlakis GN; Felber BK
    Front Immunol; 2022; 13():945706. PubMed ID: 35935984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects.
    Huang T; Peng L; Han Y; Wang D; He X; Wang J; Ou C
    Front Immunol; 2022; 13():922301. PubMed ID: 36090974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of mRNA vaccines in the management of cancer.
    Mohamad Razif MI; Nizar N; Zainal Abidin NH; Muhammad Ali SN; Wan Zarimi WNN; Khotib J; Susanti D; Mohd Jailani MT; Taher M
    Expert Rev Vaccines; 2023; 22(1):629-642. PubMed ID: 37401128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleoside-Modified mRNA Vaccines Protect IFNAR
    Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
    J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatballs foster fabulous follicles.
    Turley JL; Lavelle EC
    Immunity; 2021 Dec; 54(12):2695-2697. PubMed ID: 34910938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elucidation of lipid nanoparticle surface structure in mRNA vaccines.
    Wang MM; Wappelhorst CN; Jensen EL; Chi YT; Rouse JC; Zou Q
    Sci Rep; 2023 Oct; 13(1):16744. PubMed ID: 37798336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics.
    Mukai H; Ogawa K; Kato N; Kawakami S
    Drug Metab Pharmacokinet; 2022 Jun; 44():100450. PubMed ID: 35381574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Efficacy and Mechanism Driven Study on the Impact of Hypoxia on Lipid Nanoparticle Mediated mRNA Delivery.
    Ma Y; Fenton OS
    J Am Chem Soc; 2023 May; 145(20):11375-11386. PubMed ID: 37184377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational design of anti-inflammatory lipid nanoparticles for mRNA delivery.
    Zhang H; Han X; Alameh MG; Shepherd SJ; Padilla MS; Xue L; Butowska K; Weissman D; Mitchell MJ
    J Biomed Mater Res A; 2022 May; 110(5):1101-1108. PubMed ID: 35076171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer Vaccine.
    Li Q; Ren J; Liu W; Jiang G; Hu R
    Drug Des Devel Ther; 2021; 15():3953-3963. PubMed ID: 34566407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity.
    Provine NM; Klenerman P
    Eur J Immunol; 2023 Jun; 53(6):e2250022. PubMed ID: 36330560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses.
    Alameh MG; Tombácz I; Bettini E; Lederer K; Sittplangkoon C; Wilmore JR; Gaudette BT; Soliman OY; Pine M; Hicks P; Manzoni TB; Knox JJ; Johnson JL; Laczkó D; Muramatsu H; Davis B; Meng W; Rosenfeld AM; Strohmeier S; Lin PJC; Mui BL; Tam YK; Karikó K; Jacquet A; Krammer F; Bates P; Cancro MP; Weissman D; Luning Prak ET; Allman D; Locci M; Pardi N
    Immunity; 2021 Dec; 54(12):2877-2892.e7. PubMed ID: 34852217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate immune mechanisms of mRNA vaccines.
    Verbeke R; Hogan MJ; Loré K; Pardi N
    Immunity; 2022 Nov; 55(11):1993-2005. PubMed ID: 36351374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research Advances on the Stability of mRNA Vaccines.
    Cheng F; Wang Y; Bai Y; Liang Z; Mao Q; Liu D; Wu X; Xu M
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8
    Chen J; Ye Z; Huang C; Qiu M; Song D; Li Y; Xu Q
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2207841119. PubMed ID: 35969778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer.
    Malla R; Srilatha M; Farran B; Nagaraju GP
    Mol Ther; 2024 Jan; 32(1):13-31. PubMed ID: 37919901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine.
    Muramatsu H; Lam K; Bajusz C; Laczkó D; Karikó K; Schreiner P; Martin A; Lutwyche P; Heyes J; Pardi N
    Mol Ther; 2022 May; 30(5):1941-1951. PubMed ID: 35131437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nano-Particulate Platforms for Vaccine Delivery to Enhance Antigen-Specific CD8
    Sharma J; Carson CS; Douglas T; Wilson JT; Joyce S
    Methods Mol Biol; 2022; 2412():367-398. PubMed ID: 34918256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.